Biomatters
Auckland
About Biomatters
Biomatters creates applications for omics analysis. Our WebApp Development Group builds production quality, public- and private cloud based responsive web applications to deliver the highest usability and visualized insight for applied genomics workflows. By collaborating with clinical and molecular diagnostics developers, we build the platforms that crunch their data and deliver results reports to their customers. We turn genomic research workflows into production-ready, regulatory-compliant diagnostic pipelines. Geneious, our desktop app for research biologists, features tools for DNA/RNA/protein sequence analysis, data management, database searching, and publication-quality image generation. Geneious is used by university, government, and medical research labs worldwide in disciplines such as agricultural genomics, evolutionary biology, biofuels, synthetic biology, microbiology, virology, and next-gen sequence analysis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $11.4K
- Funding stage: M&A
- Last round: Grant (Nov 2022)
- Website: biomatters.com
- Phone: +64 9 379 5064
Industries & Categories
Artificial Intelligence (AI), Big Data, Biotechnology, Genetics, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/biomatters-127953 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.